Cite

HARVARD Citation

    Liang, L. et al. (2020). The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma. British journal of haematology. pp. 62-76. [Online]. 
  
Back to record